These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6158931

  • 21. Interferon action: role of membrane gangliosides.
    Vengris VE, Reynolds FH, Hollenberg MD, Pitha PM.
    Virology; 1976 Jul 15; 72(2):486-93. PubMed ID: 181911
    [No Abstract] [Full Text] [Related]

  • 22. Interferon-sepharose: priming of L cells for induction of interferon by MM virus.
    Knight E.
    J Gen Virol; 1974 Oct 15; 25(1):143-5. PubMed ID: 4372309
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bovine type II interferon: activity in heterologous cells.
    Babiuk LA, Rouse BT.
    Intervirology; 1977 Oct 15; 8(4):250-6. PubMed ID: 194868
    [Abstract] [Full Text] [Related]

  • 28. A cell surface alteration in mouse L cells induced by interferon.
    Knight E, Korant BD.
    Biochem Biophys Res Commun; 1977 Jan 24; 74(2):707-13. PubMed ID: 836320
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Induction and cross-species activity of rat fibroblast-derived interferon.
    Abreu SL, Cannella MS, Hanke J.
    Microbios; 1981 Jan 24; 30(121-122):181-90. PubMed ID: 6171704
    [Abstract] [Full Text] [Related]

  • 32. Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells.
    Ankel H, Krishnamurti C, Besançon F, Stefanos S, Falcoff E.
    Proc Natl Acad Sci U S A; 1980 May 24; 77(5):2528-32. PubMed ID: 6156452
    [Abstract] [Full Text] [Related]

  • 33. Characterization of two distinct molecular populations of type I mouse interferons.
    Stewart WE, LeGoff S, Wiranowska-Stewart.
    J Gen Virol; 1977 Nov 24; 37(2):277-84. PubMed ID: 200708
    [Abstract] [Full Text] [Related]

  • 34. Interferon and glycoprotein hormones.
    Friedman RM, Grollman EF, Chang EH, Kohn LD, Lee G, Jay FT.
    Tex Rep Biol Med; 1977 Nov 24; 35():326-9. PubMed ID: 211663
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differential inactivation and separation of homologous and heterologous antiviral activity of human leukocyte interferon by a proteolytic enzyme.
    Braude IA, Lin LS, Stewart WE.
    Biochem Biophys Res Commun; 1979 Jul 27; 89(2):612-9. PubMed ID: 226088
    [No Abstract] [Full Text] [Related]

  • 38. Priming of interferon action.
    Fleischmann WR.
    Tex Rep Biol Med; 1977 Jul 27; 35():316-25. PubMed ID: 616670
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The role of cell membrane in the antiviral effect of interferon.
    Pitha PM, Vengris VE, Reynolds FH.
    J Supramol Struct; 1976 Jul 27; 4(4):467-73. PubMed ID: 778494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.